Income Statement BGI Genomics Co., Ltd.

Equities

300676

CNE100003449

Biotechnology & Medical Research

End-of-day quote Shenzhen S.E. Other stock markets 2025-01-24			5-day change	1st Jan Change
38.95 ^CNY	+1.64%		-0.56%	-7.20%

Oct. 25	BGI Genomics Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024	CI
Sep. 13	BGI Genomics Gets Registration for Expanded Use of Hereditary Deafness Gene Detection Kit	MT

f.YG8fKONqMb_WquWrkEs_jaSAR7KRwBjuyoe0ua962c0.U1pmX5YoA9CQ2q_uygJxveXWDf3bmCGKstj6jMNNsYs_W2V_qCkJ2ISb1Q

Published financial data: BGI GENOMICS CO., LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	2.79B	8.39B	6.75B	7.03B	4.33B
Other Revenues, Total	6.68M	10.31M	11.75M	16.67M	16.91M
Total Revenues	2.8B	8.4B	6.77B	7.05B	4.35B
Cost of Goods Sold, Total	1.3B	3.38B	2.85B	3.52B	2.2B
Gross Profit	1.5B	5.01B	3.92B	3.53B	2.15B
Selling General & Admin Expenses, Total	827M	1.63B	1.64B	2B	1.44B
Provision for Bad Debts	99.77M	141M	105M	185M	66.41M
R&D Expenses	306M	611M	475M	526M	523M
Other Operating Expenses	8.94M	41.22M	23.95M	-10.16M	4.1M
Other Operating Expenses, Total	1.24B	2.42B	2.24B	2.7B	2.03B
Operating Income	258M	2.59B	1.68B	827M	113M
Interest Expense, Total	-5.73M	-89.04M	-105M	-101M	-91.56M
Interest And Investment Income	16.74M	119M	218M	424M	153M
Net Interest Expenses	11.01M	30.18M	113M	323M	61.77M
Currency Exchange Gains (Loss)	5.2M	-139M	-39.76M	-2.27M	-11.36M
Other Non Operating Income (Expenses)	-4.26M	-4.39M	-4.04M	-62.37M	-6.44M
EBT, Excl. Unusual Items	270M	2.48B	1.75B	1.09B	157M
Gain (Loss) On Sale Of Investments	11.56M	52.2M	86.41M	80.73M	-34.36M
Gain (Loss) On Sale Of Assets	2.69M	-4.23M	-3.88M	106K	2.76M
Asset Writedown	-1.2M	-105M	-102M	-209M	-9.25M
Legal Settlements	-	-	-	-	-
Other Unusual Items	45.6M	20.39M	15.76M	49.8M	-527K
EBT, Incl. Unusual Items	328M	2.44B	1.75B	1.01B	116M
Income Tax Expense	49.67M	340M	268M	198M	21.85M
Earnings From Continuing Operations	279M	2.1B	1.48B	809M	93.68M
Net Income to Company	279M	2.1B	1.48B	809M	93.68M
Minority Interest	-2.19M	-11.77M	-16.16M	-6.52M	-781K
Net Income - (IS)	276M	2.09B	1.46B	803M	92.9M
Preferred Dividend and Other Adjustments	-	-	700K	-	-
Net Income to Common Incl Extra Items	276M	2.09B	1.46B	803M	92.9M
Net Income to Common Excl. Extra Items	276M	2.09B	1.46B	803M	92.9M
Per Share Items
Net EPS - Basic	0.69	5.25	3.56	1.96	0.23
Basic EPS - Continuing Operations	0.69	5.25	3.56	1.96	0.23
Basic Weighted Average Shares Outstanding	400M	398M	410M	410M	410M
Net EPS - Diluted	0.69	5.24	3.55	1.96	0.23
Diluted EPS - Continuing Operations	0.69	5.24	3.55	1.96	0.23
Diluted Weighted Average Shares Outstanding	400M	399M	411M	410M	412M
Normalized Basic EPS	0.42	3.86	2.63	1.64	0.24
Normalized Diluted EPS	0.42	3.85	2.62	1.64	0.24
Dividend Per Share	0.1	0.35	0.35	1	0.1
Payout Ratio	14.48	2.98	12.16	20.81	448.58
Supplemental Items
EBITDA	496M	2.89B	1.95B	1.17B	465M
EBITA	275M	2.61B	1.71B	860M	152M
EBIT	258M	2.59B	1.68B	827M	113M
EBITDAR	521M	2.91B	1.97B	1.19B	481M
Total Revenues (As Reported)	2.8B	8.4B	-	7.05B	4.35B
Effective Tax Rate - (Ratio)	15.13	13.93	15.36	19.61	18.92
Total Current Taxes	32.24M	425M	317M	184M	45.96M
Total Deferred Taxes	17.42M	-84.5M	-49M	13.84M	-24.11M
Normalized Net Income	166M	1.54B	1.08B	672M	97.29M
Interest on Long-Term Debt	-	18.09M	36.69M	30.66M	605K
Supplemental Operating Expense Items
Advertising Expense	-	-	-	-	-
Marketing Expenses	209M	252M	589M	-	-
Selling and Marketing Expenses	610M	1.07B	1.24B	1.6B	1.03B
General and Administrative Expenses	193M	537M	379M	379M	397M
Research And Development Expense From Footnotes	317M	620M	487M	536M	529M
Net Rental Expense, Total	24.52M	23.09M	23.33M	19.06M	16.74M
Imputed Operating Lease Interest Expense	-	24.48M	18.04M	29.33M	43.38M
Imputed Operating Lease Depreciation	-	-1.39M	5.29M	-10.27M	-26.64M
Stock-Based Comp., COGS (Total)	-	-	-	-	17.91M
Stock-Based Comp., R&D Exp. (Total)	-	-	-	-	25.46M
Stock-Based Comp., S&M Exp. (Total)	-	-	-	-	45.68M
Stock-Based Comp., G&A Exp. (Total)	-	-	-	-	33.77M
Stock-Based Comp., Other (Total)	-	95.96M	196M	22.85M	-
Total Stock-Based Compensation	-	95.96M	196M	22.85M	123M

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	735M	5.43B	6.59B	5.16B	4.73B
Short Term Investments	-	-	6.57M	19.65M	-
Trading Asset Securities, Total	482M	-	2.05B	1.23B	754M
Total Cash And Short Term Investments	1.22B	5.43B	8.65B	6.41B	5.49B
Accounts Receivable, Total	1.23B	1.58B	1.24B	2.22B	1.46B
Other Receivables	103M	117M	49.74M	174M	54.22M
Notes Receivable	-	-	-	-	-
Total Receivables	1.34B	1.69B	1.29B	2.39B	1.52B
Inventory	343M	1.01B	878M	718M	602M
Other Current Assets, Total	307M	284M	217M	249M	327M
Total Current Assets	3.2B	8.42B	11.03B	9.77B	7.93B
Gross Property Plant And Equipment	1.92B	2.12B	2.42B	3.39B	4.67B
Accumulated Depreciation	-613M	-831M	-1.02B	-1.2B	-1.48B
Net Property Plant And Equipment	1.31B	1.29B	1.4B	2.19B	3.19B
Long-term Investments	613M	749M	445M	1.33B	1.25B
Goodwill	47.11M	47.11M	47.11M	47.11M	47.11M
Other Intangibles, Total	161M	147M	245M	411M	419M
Accounts Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	93.54M	162M	200M	236M	242M
Deferred Charges Long-Term	89.06M	95.89M	178M	210M	363M
Other Long-Term Assets, Total	391M	290M	705M	187M	167M
Total Assets	5.91B	11.2B	14.25B	14.38B	13.61B
Liabilities
Accounts Payable, Total	221M	873M	805M	1.02B	865M
Accrued Expenses, Total	287M	963M	653M	960M	668M
Short-term Borrowings	-	563M	5.01M	-	-
Current Portion of Long-Term Debt	-	23.7M	35.74M	-	24.18M
Current Portion of Leases	-	-	90.6M	63.33M	57.79M
Current Income Taxes Payable	25.03M	147M	168M	77.35M	59.79M
Unearned Revenue Current, Total	-	841M	1.41B	929M	700M
Other Current Liabilities	601M	391M	216M	890M	923M
Total Current Liabilities	1.13B	3.8B	3.38B	3.94B	3.3B
Long-Term Debt	-	658M	632M	-	216M
Long-Term Leases	65.83M	33.02M	84.44M	137M	67.75M
Unearned Revenue Non Current	46.02M	49.1M	36.07M	19.68M	15.39M
Deferred Tax Liability Non Current	26.17M	1.48M	5.19M	51.56M	13.13M
Other Non Current Liabilities	236M	626M	672M	-	-
Total Liabilities	1.51B	5.17B	4.81B	4.15B	3.61B
Common Stock, Total	400M	400M	414M	414M	414M
Additional Paid In Capital	2.81B	2.6B	4.66B	4.68B	4.59B
Retained Earnings	1.06B	3.16B	4.49B	5.15B	4.83B
Treasury Stock	-	-176M	-87.95M	-337M	-115M
Comprehensive Income and Other	49.98M	-78.61M	-153M	172M	143M
Total Common Equity	4.31B	5.91B	9.32B	10.08B	9.86B
Minority Interest	86.99M	116M	123M	145M	145M
Total Equity	4.4B	6.03B	9.44B	10.22B	10B
Total Liabilities And Equity	5.91B	11.2B	14.25B	14.38B	13.61B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	400M	397M	410M	410M	379M
ECS Total Common Shares Outstanding	400M	397M	410M	410M	379M
Book Value / Share	10.78	14.88	22.73	24.59	25.98
Tangible Book Value	4.11B	5.72B	9.03B	9.62B	9.39B
Tangible Book Value Per Share	10.26	14.39	22.02	23.47	24.76
Total Debt	65.83M	1.28B	848M	200M	365M
Net Debt	-1.15B	-4.15B	-7.8B	-6.21B	-5.12B
Debt Equivalent Oper. Leases	196M	185M	187M	153M	134M
Minority Interest, Total (Incl. Fin. Div)	86.99M	116M	123M	145M	145M
Equity Method Investments, Total	130M	211M	192M	317M	359M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	145M	353M	211M	312M	259M
Inventories - Work In Process, Total	13.56M	121M	135M	88.2M	72.48M
Inventories - Finished Goods, Total	184M	598M	556M	417M	307M
Buildings, Total	338M	422M	419M	490M	1.79B
Machinery, Total	1.22B	1.46B	1.61B	1.84B	2.2B
Full Time Employees	3.58K	3.78K	-	4.45K	3.75K
Assets under Capital Lease - Gross	185M	187M	5M	-	-
Assets under Capital Lease - Accumulated Depreciation	-66.3M	-99.55M	-1.2M	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	469M	588M	646M	794M	820M

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	276M	2.09B	1.46B	803M	92.9M
Depreciation & Amortization - CF	221M	281M	337M	409M	379M
Amortization of Goodwill and Intangible Assets - (CF)	17.86M	18.81M	25.85M	32.76M	39.52M
Depreciation & Amortization, Total	239M	299M	363M	441M	419M
Amortization of Deferred Charges, Total - (CF)	25.26M	28.81M	33.36M	46.3M	54.24M
(Gain) Loss From Sale Of Asset	-2.69M	4.23M	3.88M	-106K	-2.76M
(Gain) Loss on Sale of Investments - (CF)	-18.53M	-153M	-260M	-388M	33.07M
Asset Writedown & Restructuring Costs	1.2M	276M	102M	209M	20.5M
Provision and Write-off of Bad Debts	99.77M	-	105M	185M	66.41M
Other Operating Activities, Total	1.64M	101M	131M	326M	82.53M
Change In Accounts Receivable	-422M	-472M	254M	-1.06B	736M
Change In Inventories	-101M	-604M	170M	46.25M	104M
Change In Accounts Payable	108M	2.12B	148M	-483M	-1.34B
Change In Deferred Taxes	17.42M	-85.2M	-34.52M	10.36M	24.94M
Change in Other Net Operating Assets	-	-	-	-	123M
Cash from Operations	224M	3.6B	2.48B	136M	409M
Capital Expenditure	-626M	-301M	-384M	-1.27B	-1.24B
Sale of Property, Plant, and Equipment	1.3M	4.04M	709K	331K	2.72M
Cash Acquisitions	-	96.52K	-	5.2M	-
Divestitures	-	-	5.9M	-6.42K	-
Investment in Marketable and Equity Securities, Total	-263M	431M	-2.07B	566M	-764M
Other Investing Activities, Total	45.51M	59.99M	153M	111M	247M
Cash from Investing	-843M	194M	-2.29B	-584M	-1.75B
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	-	1.29B	5M	20M	252M
Total Debt Issued	-	1.29B	5M	20M	252M
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-	-25.27M	-690M	-780M	-78.77M
Total Debt Repaid	-	-25.27M	-690M	-780M	-78.77M
Issuance of Common Stock	-	-	2B	64.06M	5M
Repurchase of Common Stock	-	-	-	-337M	-
Common Dividends Paid	-40.01M	-62.29M	-178M	-167M	-417M
Common & Preferred Stock Dividends Paid	-40.01M	-62.29M	-178M	-167M	-417M
Other Financing Activities, Total	388M	-50.7M	-103M	5.48M	-28.05M
Cash from Financing	348M	1.15B	1.04B	-1.19B	-267M
Foreign Exchange Rate Adjustments	5.21M	-263M	-140M	279M	32.82M
Net Change in Cash	-265M	4.68B	1.08B	-1.36B	-1.58B
Supplemental Items
Cash Interest Paid	-	-	-	-	-
Cash Income Tax Paid (Refund)	97.06M	491M	420M	336M	145M
Levered Free Cash Flow	211M	2.77B	1.83B	-642M	-379M
Unlevered Free Cash Flow	214M	2.82B	1.89B	-579M	-322M
Change In Net Working Capital	-416M	-1.08B	-635M	339M	-248M
Net Debt Issued / Repaid	-	1.26B	-685M	-760M	173M

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	2.88	18.94	8.25	3.61	0.5
Return on Total Capital	3.69	27.52	11.91	4.99	0.68
Return On Equity %	6.44	40.32	19.11	8.23	0.93
Return on Common Equity	6.52	40.89	19.19	8.28	0.93
Margin Analysis
Gross Profit Margin %	53.56	59.72	57.95	50.07	49.37
SG&A Margin	29.55	19.41	24.2	28.38	33.12
EBITDA Margin %	17.72	34.43	28.84	16.64	10.68
EBITA Margin %	9.84	31.09	25.21	12.2	3.51
EBIT Margin %	9.2	30.86	24.83	11.73	2.6
Income From Continuing Operations Margin %	9.95	25.03	21.84	11.49	2.15
Net Income Margin %	9.87	24.89	21.6	11.4	2.14
Net Avail. For Common Margin %	9.87	24.89	21.59	11.4	2.14
Normalized Net Income Margin	5.94	18.31	15.92	9.54	2.24
Levered Free Cash Flow Margin	7.53	32.95	27.03	-9.1	-8.72
Unlevered Free Cash Flow Margin	7.66	33.61	28	-8.21	-7.41
Asset Turnover
Asset Turnover	0.5	0.98	0.53	0.49	0.31
Fixed Assets Turnover	2.27	6.46	5.04	3.93	1.62
Receivables Turnover (Average Receivables)	2.24	5.97	4.79	4.06	2.35
Inventory Turnover (Average Inventory)	4.45	5	3.01	4.41	3.34
Short Term Liquidity
Current Ratio	2.82	2.21	3.26	2.48	2.41
Quick Ratio	2.25	1.87	2.94	2.23	2.12
Operating Cash Flow to Current Liabilities	0.2	0.95	0.73	0.03	0.12
Days Sales Outstanding (Average Receivables)	163.12	61.27	76.19	89.83	155.27